The way I see this is simple:
Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+
If you add another rare disease to the mix, this valuation will increase the new valuation.
If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.
So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.
For me, it's one of the most simple stock picks around to generate further profits.
xoxo
Merry Christmas all.
- Forums
- ASX - By Stock
- NEU
- Take Over Opportunity
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.59%
!
$19.82

Take Over Opportunity
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$19.82 |
Change
-0.320(1.59%) |
Mkt cap ! $2.503B |
Open | High | Low | Value | Volume |
$20.39 | $20.83 | $19.70 | $21.46M | 1.066M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7078 | $19.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.94 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 19.800 |
1 | 310 | 19.750 |
1 | 1000 | 19.710 |
2 | 10581 | 19.700 |
1 | 1000 | 19.650 |
Price($) | Vol. | No. |
---|---|---|
19.950 | 18749 | 1 |
20.000 | 400 | 1 |
20.200 | 5000 | 1 |
20.390 | 1000 | 1 |
20.400 | 1150 | 1 |
Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |